July 2025 has emerged as one of the most exciting months in the Indian IPO landscape, with the spotlight on July 2025 IPOs in India making waves across stock market circles.
From booming tech startups to leading biotech firms, this month offers opportunities for every type of investor. Whether you’re aiming for short-term listing gains or planning long-term investments, these IPOs are worth your attention.
Why July 2025 IPOs in India Are Generating Buzz
India’s bullish market sentiment and positive economic indicators are fueling a surge in primary market activity.
Here’s why investors are flocking to IPOs this month:
- Strong institutional participation across several listings
- Diverse sector representation – from cybersecurity to biotech
- High GMPs and strong oversubscription trends
Many of these IPOs are aligned with India’s growth in digital infrastructure, healthcare innovation, and tech services.
Top IPOs to Watch This Month
Meta Infotech (BSE SME)
- IPO Dates: July 4–8, 2025
- Price Band: ₹153–161
- Lot Size: 800 shares (~₹1.28 lakh)
- Grey Market Premium (GMP): ₹25–40
- Sector: Cybersecurity, IT services
Highlights:
- Specializes in government and enterprise cybersecurity solutions
- FY25 revenue: ₹220 crore; PAT: ₹16.8 crore
- Raised ₹22.5 crore from anchor investors pre-issue
Risks: Volatility due to SME listing, limited liquidity
Cryogenic OGS Ltd (BSE SME)
- IPO Dates: July 3–7, 2025
- Price Band: ₹44–47
- Lot Size: 3,000 shares (~₹1.32 lakh)
- GMP: ₹22
- Sector: Cryogenic gas & equipment
Key Highlights:
- Oversubscribed 62 times by Day 3
- FY25 revenue: ₹32.9 crore; PAT: ₹6.1 crore
- Supplies to pharma, steel, and oil & gas sectors
Risks: Capital-intensive operations, raw material price fluctuations
Crizac Ltd (Mainboard)
- IPO Dates: July 2–4, 2025
- Price Band: ₹233–245
- Lot Size: 61 shares (~₹14,945)
- GMP: ₹39
- Sector: EdTech, international education consulting
Strengths:
- Oversubscribed 60 times; QIBs alone subscribed 134 times
- Well-known global student advisory brand
Risks: Highly dependent on international visa and migration policies
White Force (NSE SME)
- IPO Dates: July 3–7, 2025
- Price Band: ₹61–65
- Lot Size: 2,000 shares (~₹1.22 lakh)
- Sector: Recruitment, staffing
Snapshot:
- Offers nationwide staffing and payroll solutions
- Subscription data still pending
Risks: Intense competition, sensitive to hiring trends
Anthem Biosciences (Mainboard)
- IPO Dates: July 14–16, 2025
- Issue Size: ₹3,395 crore (Offer for Sale)
- Sector: Biotech, Contract Research & Manufacturing
Financials:
- FY24 revenue: ₹1,483 crore
- PAT: ₹367 crore
- Peers: Syngene, Divi’s Laboratories
Risks: Regulatory compliance (e.g., USFDA), global demand sensitivity
Side-by-Side IPO Comparison Table
| IPO Name | Price Band | GMP (₹) | Subscription | Listing Date |
|---|---|---|---|---|
| Meta Infotech | 153–161 | 25–40 | Ongoing | July 11 |
| Cryogenic OGS | 44–47 | 22 | 62x+ | July 10 |
| Crizac Ltd | 233–245 | 39 | 60x+ | July 9 |
| White Force | 61–65 | TBD | Active | TBD |
| Anthem Biosciences | TBA | TBA | TBA | July 21 (est.) |
How to Choose the Right July 2025 IPO
Tips for Indian investors evaluating IPOs:
- Track GMP daily – rising GMP often signals strong demand
- Assess QIB and anchor interest – big players add credibility
- Understand the company’s business model – don’t invest blindly
- Use reliable platforms – Zerodha, Groww, Angel One for applications
Final Thoughts on July 2025 IPOs in India
The July 2025 IPO season in India presents a great mix of growth and opportunity.
Whether you’re eyeing listing gains or long-term value, now is the time to stay IPO-ready. With diverse sectors and strong investor interest, these IPOs are worth your consideration.
🚀 Call-to-Action:
Which IPO are you applying for this July? Share your picks in the comments, forward this to your investing circle, and follow us for more IPO insights. read more blogs at quillfin.com
Disclaimer:
This blog post is intended for informational purposes only and does not offer financial advice. Investing in IPOs carries risks. Readers should perform their own research or consult a certified financial advisor before making any investment decisions.
Siddharth Suryavanshi is a finance enthusiast with over 8 years of hands-on experience in the stock market. Having served as a sub-broker at Motilal Oswal for 2 years, he brings in-depth knowledge and practical insights from the heart of the industry. Siddharth specializes in both technical and fundamental analysis, offering a well-rounded perspective on market trends and investment strategies.